A pilot study to evaluate MN-166 (ibudilast) in chemotherapy-induced peripheral neuropathy

Trial Profile

A pilot study to evaluate MN-166 (ibudilast) in chemotherapy-induced peripheral neuropathy

Planning
Phase of Trial: Phase II

Latest Information Update: 04 Apr 2018

At a glance

  • Drugs Ibudilast (Primary)
  • Indications Peripheral neuropathies
  • Focus Therapeutic Use
  • Most Recent Events

    • 04 Apr 2018 New trial record
    • 28 Mar 2018 According to a MediciNova media release, a Concord Cancer Centre Research grant will provide funding for this study and MediciNova will provide study drug.
    • 28 Mar 2018 According to a MediciNova media release, the clinical trial is a collaborative effort between MediciNova and Dr. Janette Vardy (the Principal Investigator for this study), Professor of Cancer Medicine, University of Sydney Concord Cancer Centre in Australia.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top